Home › Niet-kleincellige longkanker › Illinois › Cicero
Niet-kleincellige longkanker klinische studies in Cicero, IL
24 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Cicero (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RekruterenFase 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 mijl verwijderd
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Edward Hines Jr VA Hospital, Hines · 4 mijl verwijderd
- Advocate Christ Medical Center, Oak Lawn · 9 mijl verwijderd
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruterenFase 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mijl verwijderd
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruterenFase 3
- Hope and Healing Cancer Services, Hinsdale · 10 mijl verwijderd
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekruterenFase 3
- Advocate Christ Medical Center, Oak Lawn · 9 mijl verwijderd
- Hope and Healing Cancer Services, Hinsdale · 10 mijl verwijderd
- Endeavor Health, Elmhurst · 10 mijl verwijderd
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RekruterenFase 2
- Hope and Healing Clinical Research, Hinsdale · 10 mijl verwijderd
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RekruterenFase 3
- Research Site, Hinsdale · 10 mijl verwijderd
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RekruterenFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mijl verwijderd
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekruterenFase 3
- Research Site, Hinsdale · 10 mijl verwijderd
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekruterenFase 2/3
- Loyola University Medical Center, Maywood · 5 mijl verwijderd
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RekruterenFase 3
- Hope and Healing Cancer Services, Hinsdale · 10 mijl verwijderd
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruterenFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mijl verwijderd
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekruterenFase 3
- Research Site, Hinsdale · 10 mijl verwijderd
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekruterenFase 3
- Research Site, Hinsdale · 10 mijl verwijderd
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RekruterenFase 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mijl verwijderd
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekruterenFase 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mijl verwijderd
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mijl verwijderd
- Edward Hines Jr VA Hospital, Hines · 4 mijl verwijderd
- Loyola University Medical Center, Maywood · 5 mijl verwijderd
- en nog 2
MYLUNG Consortium Part 3: Observational Study
RekruterenObservatieonderzoek
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mijl verwijderd
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Edward Hines Jr VA Hospital, Hines · 4 mijl verwijderd
- Loyola University Medical Center, Maywood · 5 mijl verwijderd
- Northwestern Medicine Oak Brook, Oak Brook · 9 mijl verwijderd
- en nog 3
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Loyola University Medical Center, Maywood · 5 mijl verwijderd
- Northwestern Medicine Oak Brook, Oak Brook · 9 mijl verwijderd
- Advocate Christ Medical Center, Oak Lawn · 9 mijl verwijderd
- en nog 2
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Edward Hines Jr VA Hospital, Hines · 4 mijl verwijderd
- Loyola University Medical Center, Maywood · 5 mijl verwijderd
- Northwestern Medicine Oak Brook, Oak Brook · 9 mijl verwijderd
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- Advocate Christ Medical Center, Oak Lawn · 9 mijl verwijderd
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mijl verwijderd
- Advocate High Tech Medical Park, Palos Heights · 12 mijl verwijderd
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Rekruteren
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mijl verwijderd
GEMINI-NSCLC: NSCLC Biomarker Study
RekruterenObservatieonderzoek
- Hope and Healing Cancer Services, Hinsdale · 10 mijl verwijderd
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Andere studies in Cicero
- Longkanker17 studies
- Prostaatkanker14 studies
- Kanker (alle vormen)13 studies
- Borstkanker11 studies
- Acute myeloïde leukemie11 studies
- Colorectale kanker10 studies
- Blasenkanker8 studies
- Melanoom7 studies
- Cardiovasculaire ziekte7 studies
- Metastatische kanker7 studies
- Multipel myeloom6 studies
- Burkitt-lymfoom6 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.